Sign inJoin waitlistJoin the waitlist

Jared Acoba

Program Director · University of Hawaii John A Burns School of Medicine

Credentials: · · · ·

History

University of Hawaii John A Burns School of Medicine
Present
Subspecialty Education · University of Hawaii John A Burns School of Medicine
Present
Gastrointestinal Cancer Education · University of Hawai‘i, John A. Burns School of Medicine
Present

University of Hawaii at Manoa
2004–2006
University of Hawaii John A Burns School of Medicine
2001–2004
Hematology and Medical Oncology
Oregon Health & Science University Program
2001–2004
Univ of Hawaii John A Burns Sch of Med
1997–2001
UC Berkeley
1996

Research

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
Annals of Oncology · 2021 · 260 citations
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors
New England Journal of Medicine · 2025 · 127 citations
Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds
Proceedings of the National Academy of Sciences of the United States of America · 2009 · 44 citations

Chalothorn Wannaphut
7 papers
LW
Linda Wong
5 papers
Manasawee Tanariyakul
5 papers · 5 as a fellow
Babar Bashir
4 papers
Gayathri Nagaraj
4 papers
SK
Sandi Kwee
4 papers
Toshiaki Takahashi
4 papers · 4 as a fellow
Vadim Koshkin
4 papers
AO
Adham Obeidat
3 papers
Ali Khaki
3 papers
Chinmay Jani
3 papers
Clara Hwang
3 papers

Grants

The Hawaii NCORP
National Cancer Institute · UG1
Contact PI · $10.9M · University of Hawaii at Manoa
2014–2027

Clinical trials

Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer
Principal investigator · Recruiting · Phase 1
University of Hawaii
2026–2027
TSR-022 (Anti-TIM-3 Antibody) and TSR-042 (Anti-PD-1 Antibody) in Patients With Liver Cancer
Principal investigator · Active not recruiting · Phase 2
University of Hawaii
2019–2027
Clinical Study of Atezolizumab (Anti-PD-L1) and Sipuleucel-T in Patients With Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer
Principal investigator · Completed · Phase 1
University of Hawaii
2017–2020
Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer
Principal investigator · Withdrawn · Phase 1
University of Hawaii
2014–2016